However, Empagliflozin treatment did not affect the amount of Iba-1+ microglia in the ipsilateral hemisphere, suggesting that the beneficial effect of Empagliflozin on stroke recovery was not due to attenuated T2D-induced inflammation, at least not at the 5 weeks post-stroke timepoint, when the mice were sacrificed. This evidence concerns the gene AIF1 and Stroke.